5 completed. 5 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 5 |
Follow Stage IV Endometrial Carcinoma: new trials by email Literature Review of Stage IV Endometrial Carcinoma trials Research Report on Stage IV Endometrial Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanced Solid Tumors temsirolimus, gamma-secretase/Notch signalling pathway inhibitor RO4929097, laboratory biomarker analysis - Endometrial Papillary Serous Carcinoma, Recurrent Endometrial Carcinoma | Phase 1 | Completed | National Cancer Institute (NCI) | 18 | 2010-08-01 | 2014-05-30 |
| Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors temsirolimus, vinorelbine ditartrate - Extensive Stage Small Cell Lung Cancer, Hereditary Paraganglioma | Phase 1 | Completed | University of Southern California | 19 | 2010-06-01 | 2016-06-13 |
| Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors paclitaxel, carboplatin, temsirolimus - Ovarian Sarcoma, Ovarian Stromal Cancer | Phase 1 | Completed | National Cancer Institute (NCI) | 38 | 2007-02-01 | 2014-06-19 |
| 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) 7-hydroxystaurosporine, irinotecan hydrochloride, diagnostic laboratory biomarker analysis - Advanced Adult Primary Liver Cancer, Carcinoma of the Appendix | Phase 1 | Completed | National Cancer Institute (NCI) | 41 | 2001-12-01 | 2013-09-30 |
| Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu recombinant interleukin-12, ABI-007/carboplatin/trastuzumab - Advanced Adult Primary Liver Cancer, Anaplastic Thyroid Cancer | Phase 1 | Completed | National Cancer Institute (NCI) | 15 | 1999-08-01 | 2013-02-28 |
Endometrial Neoplasms (5) · Carcinoma, Ovarian Epithelial (4) · Breast Neoplasms (3) · Carcinoma, Non-Small-Cell Lung (3) · Carcinoma, Renal Cell (3) · Prostatic Neoplasms (3) · Uterine Cervical Neoplasms (3) · Anus Neoplasms (2) · Appendiceal Neoplasms (2) · Bile Duct Neoplasms (2) · Breast Neoplasms, Male (2) · Carcinoma, Hepatocellular (2) · Carcinoma, Islet Cell (2) · Carcinoma, Medullary (2) · Colonic Neoplasms (2)
Carcinoma (5) · Female Urogenital Diseases (5) · Female Urogenital Diseases and Pregnancy Complications (5) · Genital Diseases (5) · Genital Diseases, Female (5) · Genital Neoplasms, Female (5) · Neoplasms (5) · Neoplasms by Histologic Type (5) · Neoplasms by Site (5) · Neoplasms, Glandular and Epithelial (5) · Urogenital Diseases (5) · Urogenital Neoplasms (5) · Uterine Diseases (5) · Uterine Neoplasms (5) · Adenocarcinoma (4)
Sirolimus (3) · temsirolimus (3) · 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide (1) · 7-hydroxystaurosporine (1) · Carboplatin (1) · Interleukin-12 (1) · Interleukin-12 Subunit p35 (1) · Irinotecan (1) · Paclitaxel (1) · Taxes (1) · Trastuzumab (1) · Vinorelbine (1)
National Cancer Institute (NCI) (4) · University of Southern California (1)
United States (3) · Canada (2)
Amit Oza (2) · Agustin Garcia (1) · Paula Fracasso (1) · William Carson (1)
P30CA044579 (1), U01CA076576 (1), U01CA132123 (1)